Canada places USD 56m monkeypox vaccine order at Bavarian Nordic

Bavarian Nordic’s vaccine is approved for monkeypox in the country, where it is called Imvamune.
Photo: Bavarian Nordic / PR
Photo: Bavarian Nordic / PR
by marketwire, translated by catherine brett

The Canadian Government has signed a multi-year contract with Bavarian Nordic for supplies of its monkeypox vaccine. The contract has an estimated value of USD 56m.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading